329871 Erythropoietin, Human, Recombinant, CHO Cells

329871
View Pricing & Availability

Overview

Replacement Information

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
329871-50UG
Retrieving availability...
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Plastic ampoule 50 μg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewRecombinant, human erythropoietin (EPO) expressed in CHO cells. EPO is a glycoprotein produced by the kidneys and is involved in red blood cell production. It has a predicted molecular mass of ~21 kDa but migrates at ~37 kDa on SDS-PAGE.
      Sialic acid content: > 10 moles/mole of protein.
      Catalogue Number329871
      Brand Family Calbiochem®
      SynonymsEPO, Erythropoietin-α
      References
      ReferencesFrank, S.J. 2002. Endocrinology 143, 2.
      Cerami, A. 2001. Semin. Hematol. 38, 33.
      Donnelly, S. 2001. Am. J. Kidney Dis. 38, 415.
      Goodnough, L.T. 2001. Curr. Opin. Hematol. 8, 405.
      Jelkmann, W, and Hellwig-Burgel, T. 2001. Adv. Exp. Med. Biol. 502, 169.
      Siren, A.L., and Ehrenreich, H. 2001. Eur. Arch. Psychiatry Clin. Neurosci 251, 179.
      Hansson, G.K., et al. 1992. Scand. J. Clin. Lab. Invest. 52, 35.
      Lee, L.G., et al. 1986. Cytometry 7, 35.
      Product Information
      CAS number11096-26-7
      FormLiquid
      FormulationIn 300 mM NaCl, 20 mM Na/K phosphate, pH 7.5.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by HPLC
      Specific Activity≥1.0 X 10⁵ IU/mg protein
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      ContaminantsEndotoxin: <10 EU/10 µg protein
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSKF5885000
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C or -70°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C, up to 3 months at -20°C, or up to 6 months at -70°C. Avoid freeze/thaw cycles of solutions.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Erythropoietin, Human, Recombinant, CHO Cells Certificates of Analysis

      TitleLot Number
      329871

      References

      Reference overview
      Frank, S.J. 2002. Endocrinology 143, 2.
      Cerami, A. 2001. Semin. Hematol. 38, 33.
      Donnelly, S. 2001. Am. J. Kidney Dis. 38, 415.
      Goodnough, L.T. 2001. Curr. Opin. Hematol. 8, 405.
      Jelkmann, W, and Hellwig-Burgel, T. 2001. Adv. Exp. Med. Biol. 502, 169.
      Siren, A.L., and Ehrenreich, H. 2001. Eur. Arch. Psychiatry Clin. Neurosci 251, 179.
      Hansson, G.K., et al. 1992. Scand. J. Clin. Lab. Invest. 52, 35.
      Lee, L.G., et al. 1986. Cytometry 7, 35.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision19-November-2007 JSW
      SynonymsEPO, Erythropoietin-α
      DescriptionRecombinant, human erythropoietin (EPO) expressed in CHO cells. EPO is a glycoprotein hormone produced by the kidneys that is involved in the survival, growth, and differentiation of erythroid precursor cells. Stimulation of erythropoiesis involves the binding of EPO to the extracellular domain of the EPO receptor (EPOR) and triggering of intracellular signaling events, including phosphorylation of the receptor and activation of the JAK-STAT, RAS, and PI3-kinase pathways. Reported to act as a neuroprotective agent. Expressed in and purified from CHO cells. The predicted molecular weight is ~21 kDa, but it migrates at ~37 kDa on SDS-PAGE. Sialic acid content: > 10 moles/mole of protein. Sialic acid content: > 10 moles/mole of protein.
      FormLiquid
      FormulationIn 300 mM NaCl, 20 mM Na/K phosphate, pH 7.5.
      Concentration Label Please refer to vial label for lot-specific concentration
      CAS number11096-26-7
      RTECSKF5885000
      Purity≥98% by HPLC
      ContaminantsEndotoxin: <10 EU/10 µg protein
      Specific activity≥1.0 X 10⁵ IU/mg protein
      SolubilityReconstitute with 500 µl H₂O or aqueous buffer.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C or -70°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C, up to 3 months at -20°C, or up to 6 months at -70°C. Avoid freeze/thaw cycles of solutions.
      Toxicity Standard Handling
      Merck USA index14, 3688
      ReferencesFrank, S.J. 2002. Endocrinology 143, 2.
      Cerami, A. 2001. Semin. Hematol. 38, 33.
      Donnelly, S. 2001. Am. J. Kidney Dis. 38, 415.
      Goodnough, L.T. 2001. Curr. Opin. Hematol. 8, 405.
      Jelkmann, W, and Hellwig-Burgel, T. 2001. Adv. Exp. Med. Biol. 502, 169.
      Siren, A.L., and Ehrenreich, H. 2001. Eur. Arch. Psychiatry Clin. Neurosci 251, 179.
      Hansson, G.K., et al. 1992. Scand. J. Clin. Lab. Invest. 52, 35.
      Lee, L.G., et al. 1986. Cytometry 7, 35.